Reagent and Labor Cost Optimization through Automation of Fluorescence In Situ Hybridization (FISH) with the VP 2000
暂无分享,去创建一个
Lucia Zanatta | Laura Valori | Eleonora Cappelletto | Maria Elena Pozzebon | Elisabetta Pavan | Angelo Paolo Dei Tos | Dennis Merkle | A. D. Dei Tos | L. Zanatta | D. Merkle | L. Valori | E. Pavan | M. Pozzebon | Eleonora Cappelletto
[1] I. C. Llenos,et al. Immunohistochemistry as a screening tool for ALK rearrangement in NSCLC: evaluation of five different ALK antibody clones and ALK FISH , 2014, Histopathology.
[2] A. Shaw,et al. Novel targets in non-small cell lung cancer: ROS1 and RET fusions. , 2013, The oncologist.
[3] Tianhong Li,et al. Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] M. Dietel,et al. EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations , 2012, Virchows Archiv.
[5] J. Hainfellner,et al. FISH-based detection of 1p 19q codeletion in oligodendroglial tumors: procedures and protocols for neuropathological practice - a publication under the auspices of the Research Committee of the European Confederation of Neuropathological Societies (Euro-CNS). , 2011, Clinical neuropathology.
[6] James A. Lee,et al. Clinical and health economic outcomes of alternative HER2 test strategies for guiding adjuvant trastuzumab therapy , 2011, Expert review of pharmacoeconomics & outcomes research.
[7] C. Miller,et al. Gone FISHing: Clinical Lessons Learned in Brain Tumor Molecular Diagnostics over the Last Decade , 2011, Brain pathology.
[8] T. McCalmont. Gone FISHing , 2010, Journal of cutaneous pathology.